Yüklüyor......
Mcl-1 degradation is required for targeted therapeutics to eradicate colon cancer cells
The Bcl-2 family protein Mcl-1 is often degraded in cancer cells subjected to effective therapeutic treatment, and defective Mcl-1 degradation has been associated with intrinsic and acquired drug resistance. However, a causal relationship between Mcl-1 degradation and anticancer drug responses has n...
Kaydedildi:
| Yayımlandı: | Cancer Res |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5626525/ https://ncbi.nlm.nih.gov/pubmed/28202514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-16-3242 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|